DO CHARACTERISTICS OF PATIENTS INFLUENCING THE CHOICE OF PAIN TREATMENT BY GPS DIFFER IN OSTEOARTHRITIS AND CANCER? – AN ITALIAN REAL WORLD EVIDENCE STUDY
Author(s)
Heiman F, Pegoraro V, Moretti R
QuintilesIMS, Milan, Italy
OBJECTIVES: To understand whether patients’ features underneath the choice of pain treatments by Italian GPs differ between osteoarthritis and cancer. METHODS: Retrospective analysis on Real World Data from IMS Health Italian Longitudinal Patient Database. For both osteoarthritis and cancer, three cohorts of patients have been identified based on anti-inflammatory and antirheumatic (M01) and analgesic (N02) drugs prescriptions recorded during 2016: a) patients receiving a treatment with M01 drugs and not having N02 prescriptions, b) patients receiving a treatment with N02 and not having M01 prescriptions, c) patients treated with both M01 and N02 drugs. Descriptive statistics, Chi-square and t-tests were used to compare demographic and clinical characteristics of the patients in the three cohorts for osteoarthritis and cancer. RESULTS: Patients receiving a treatment with M01 drugs were 32,238 (70%) and 2,496 (31%) for osteoarthritis and cancer, respectively. Patients receiving a treatment with N02 were 8,569 (19%) and 4,450 (55%) for osteoarthritis and cancer, respectively. Patients treated with both M01 and N02 drugs were 5,026 (11%) and 1,107 (14%) for osteoarthritis and cancer, respectively. In osteoarthritis, the highest proportion of men was observed among patients treated with M01 only (33% versus 25% and 25%), while in cancer, higher proportions of men were observed among patients treated with N02 and among those treated with both M01 and N02 (46% and 47% versus 41%). For osteoarthritis, as well as for cancer, the oldest patients were those treated with N02 only, with a mean age of 77 and 71 years, respectively. Both in osteoarthritis and in cancer, patients treated with N02 only and with both N02 and M01 had a more impaired health status. All the comparisons were statistically significant. CONCLUSIONS: Despite all the considered patients’ features seem to be correlated with treatment choice, only gender shows opposite effects when comparing osteoarthritis and cancer.
Conference/Value in Health Info
2017-11, ISPOR Europe 2017, Glasgow, Scotland
Value in Health, Vol. 20, No. 9 (October 2017)
Code
PSY11
Topic
Epidemiology & Public Health
Topic Subcategory
Safety & Pharmacoepidemiology
Disease
Musculoskeletal Disorders, Oncology, Systemic Disorders/Conditions